Skip to content

Rehabilitation in Parkinson Disease Cyclone in Life

IR3MA Parkinson Cyclone in Life: Innovation, R3 Rehabilitation - Resonance - RTD Fluxgate Sensor, Multidisciplinary Approach

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05802498
Acronym
IRMA
Enrollment
24
Registered
2023-04-06
Start date
2020-07-21
Completion date
2023-01-20
Last updated
2023-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease, Physical Disability

Brief summary

Comparison of two rehabilitation protocols in patients with Parkinson's disease and, therefore, identification of innovative rehabilitation protocols of proven and validated efficacy, through which it is possible to achieve: * Improved joint function and gait pattern * Reduction of the risk of falling or reduction of energy expenditure during physiological gait Evaluation of the increase in maximal effort tolerance · Improved cognitive performances Evaluation of the impact on the quality of life of the patient and family members Identification of morpho-functional markers predictive of clinical and rehabilitative out-come through neuroimaging study.

Detailed description

rehabilitation protocols in patients with Parkinson's disease and, therefore, identification of innovative rehabilitation protocols of proven and validated efficacy, through which it is possible to achieve: Improved joint function and gait pattern Reduction of the risk of falling or reduction of energy expenditure during physiological gait Evaluation of the increase in maximal effort tolerance · Improved cognitive performances Evaluation of the impact on the quality of life of the patient and family members Identification of morpho-functional markers predictive of clinical and rehabilitative out-come through neuroimaging study.

Interventions

DEVICEIRMA

For patients in an advanced state of illness, advanced neuromotor rehabilitation treatment included 1) robot therapies, 2) specific water courses (e.g. walking pools, hydrokinesiotherapy pools, etc.), 3) advanced cognitive treatments (e.g. virtual reality courses); 4) augmentative immersive therapy in a virtual environment; 5) courses also dedicated to social reintegration and inclusive activities (theatre-therapy, art-therapy, dance-therapy, agro-therapy, etc.).

Sponsors

IRCCS Centro Neurolesi Bonino Pulejo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Hoehn & Yahr between 2.0 and 3.0; * No need for a walking aid; * Mini-Mental State Examination (MMSE) score \>24; * Effective dopaminergic pharmacological control; * Absence of other relevant neurological comorbidities; * Absence of postural deformities (and/or Pisa syndrome); * Absence of severe cardiological pathologies (exertional angina, severe decompensation). * Ability to travel to the rehabilitation treatment site independently or with support

Exclusion criteria

* presence of Deep Brain Stimulation (DBS); * presence of severe heart and/or lung disease; * presence of therapeutic regimen in the definition phase; * impaired joint and/or motor function to follow a proposed rehabilitation treatment programme * contraindications to performing MRI scans * undergoing rehabilitation therapy in the 3 months preceding enrolment.

Design outcomes

Primary

MeasureTime frameDescription
Berg Balance Scale (BBS)8 weeksThe Berg Balance Scale is a scale for assessing balance and the risk of falling

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026